Nobex Corporation To Auction Off Assets In March

Less than two years after its $283 million deal with GlaxoSmithKline crumbled, Nobex Corp.'s spiraling decline could be nearing an end - one way or another. The Durham-based drug development company, which raised more than $80 million in its 13-year history and employed 50 people in its prime, is being led to the auction block by the Delaware Bankruptcy Court.

Back to news